Correlation Between Basilea Pharmaceutica and OC Oerlikon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and OC Oerlikon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and OC Oerlikon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Basilea Pharmaceutica AG and OC Oerlikon Corp, you can compare the effects of market volatilities on Basilea Pharmaceutica and OC Oerlikon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of OC Oerlikon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and OC Oerlikon.

Diversification Opportunities for Basilea Pharmaceutica and OC Oerlikon

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Basilea and OERL is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and OC Oerlikon Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OC Oerlikon Corp and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with OC Oerlikon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OC Oerlikon Corp has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and OC Oerlikon go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and OC Oerlikon

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 0.68 times more return on investment than OC Oerlikon. However, Basilea Pharmaceutica AG is 1.46 times less risky than OC Oerlikon. It trades about -0.21 of its potential returns per unit of risk. OC Oerlikon Corp is currently generating about -0.15 per unit of risk. If you would invest  4,365  in Basilea Pharmaceutica AG on September 4, 2024 and sell it today you would lose (270.00) from holding Basilea Pharmaceutica AG or give up 6.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Basilea Pharmaceutica AG  vs.  OC Oerlikon Corp

 Performance 
       Timeline  
Basilea Pharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Basilea Pharmaceutica AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
OC Oerlikon Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OC Oerlikon Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Basilea Pharmaceutica and OC Oerlikon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Basilea Pharmaceutica and OC Oerlikon

The main advantage of trading using opposite Basilea Pharmaceutica and OC Oerlikon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, OC Oerlikon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OC Oerlikon will offset losses from the drop in OC Oerlikon's long position.
The idea behind Basilea Pharmaceutica AG and OC Oerlikon Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.